查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1427936

2024 年寡核苷酸合成全球市场报告

Oligonucleotide Synthesis Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

寡核苷酸合成市场规模预计在未来几年将快速成长。预计到 2028 年将以 16.1% 的复合年增长率 (CAGR) 增长至 186.7 亿美元。预测期内的预期成长可归因于新诊断工具的出现、 RNA干扰（RNAi）疗法的发展、再生医学的进步、奈米技术的应用以及基因编辑技术的进步。预测期内预计的显着趋势包括标靶药物开发、创新递送系统、自动化合成、CRISPR-Cas 技术的采用以及次世代定序仪(NGS) 的持续发展。

寡核苷酸合成市场的预期成长预计将由慢性病盛行率的增加所推动。持续超过一年并需要持续治疗的慢性疾病是全球健康问题。寡核苷酸透过各种机制影响基因表现，在解决慢性疾病方面发挥重要作用。它们可以针对 mRNA、前 mRNA 或非非编码RNA，以调节剪接事件、诱导降解或干扰蛋白质翻译。例如，2022年1月，国际糖尿病联盟报告称，预计2045年全球糖尿病盛行率将增加12.2%，达到20-79岁人口5.366亿。此外，根据世界卫生组织 2022 年 9 月的数据，心血管疾病、癌症、慢性呼吸道疾病和糖尿病等慢性疾病在全球非传染性疾病相关死亡中占很大比例（74%）。据估计，每年有4100 万人死亡。罕见疾病是推动寡核苷酸合成市场成长的关键驱动力。

对个人化医疗的需求不断增长预计将有助于市场成长。个人化医疗，也称为精准医疗，利用个体的遗传和分子特征来制定预防和治疗策略。寡核苷酸合成透过提供由合成修饰的 RNA 或 DNA 链组成的针对特定细胞过程的小分子药物，在精准医学的发展中发挥重要作用。 2022年10月，个人化医疗联盟（PMC）宣布推出超过75,000种基因感染疾病产品和300种个人化报告化学药物将引进市场。因此，对个人化医疗不断增长的需求已被确定为寡核苷酸合成市场成长的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球寡核苷酸合成市场，按类型细分、实际和预测，2018-2023、2023-2028、2033
  • 自订核苷酸
  • 预先设计的寡核苷酸
  • 全球寡核苷酸合成市场，依产品类型、效能和预测细分，2018-2023、2023-2028、2033
  • 寡核苷酸
  • 试剂
  • 装置
  • 服务
  • 精製
  • 更正
  • 全球寡核苷酸合成市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 治疗用途
  • 研究用途
  • 诊断用途

第 7 章 区域与国家分析

  • 全球寡核苷酸合成市场，依地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球寡核苷酸合成市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 寡核苷酸合成市场竞争形势
  • 寡核苷酸合成市场公司概况
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • GE HealthCare Technologies Inc.
    • Eurofins Scientific SE

第31章 其他大型创新公司

  • Agilent Technologies Inc.
  • Nitto Denko Avecia Inc.
  • Alnylam Pharmaceuticals Inc.
  • Maravai Life Sciences
  • LGC Limited
  • Ionis Pharmaceuticals Inc.
  • GenScript Inc.
  • Ajinomoto Bio-Pharma Services
  • Sarepta Therapeutics Inc.
  • Integrated DNA Technologies Inc.
  • Twist Bioscience Corporation
  • Eurogentec SA
  • Kaneka Eurogentec SA
  • Biocomma Limited
  • Bio-Synthesis Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13780

Oligonucleotide synthesis refers to the chemical process of linking nucleotides in a precise sequence, resulting in the formation of a desired product. This method is widely utilized in modern laboratory practices, providing a rapid and cost-effective means to obtain customized oligonucleotides with specific sequences.

There are two primary types of oligonucleotide synthesis, custom oligos and predesigned oligos. Custom oligos are produced through solid-phase chemical synthesis, where the nucleic acids A, T, C, and G are sequentially added to create a chain of nucleotides. The range of products involved in this process includes oligonucleotides, reagents, equipment, services, purification, and modification. These products find applications in various fields, such as therapeutic applications, research applications, and diagnostic applications. Oligonucleotide synthesis is a versatile tool that plays a crucial role in creating tailored genetic sequences for diverse purposes in the scientific and medical communities.

The oligonucleotide synthesis market research report is one of a series of new reports from The Business Research Company that provides oligonucleotide synthesis market statistics, including oligonucleotide synthesis industry global market size, regional shares, competitors with a oligonucleotide synthesis market share, detailed oligonucleotide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the oligonucleotide synthesis industry. This oligonucleotide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oligonucleotide synthesis market size has grown rapidly in recent years. It will grow from $8.85 billion in 2023 to $10.27 billion in 2024 at a compound annual growth rate (CAGR) of 16.0%. The expansion observed during the historical period can be attributed to several factors, including advancements in biomedical research, the development of therapeutics, innovations in biotechnology, genomic studies, and the increasing utilization of DNA technologies.

The oligonucleotide synthesis market size is expected to see rapid growth in the next few years. It will grow to $18.67 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The anticipated growth in the forecast period can be attributed to the emergence of new diagnostic tools, the development of RNA interference (RNAi) therapies, advancements in regenerative medicine, applications of nanotechnology, and progress in gene editing technologies. Noteworthy trends expected in the forecast period encompass targeted drug development, innovative delivery systems, automated synthesis, the adoption of CRISPR-Cas technology, and the continued evolution of next-generation sequencing (NGS).

The projected growth in the oligonucleotide synthesis market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting one year or longer and requiring ongoing medical attention, are a global health concern. Oligonucleotides play a crucial role in addressing chronic diseases by acting on gene expression through various mechanisms. They can target mRNA, pre-mRNA, or non-coding RNA to modulate splicing events, induce degradation, or interfere with protein translation. For instance, the global prevalence of diabetes is projected to increase by 12.2% in 2045, reaching 536.6 million individuals in the 20-79 age group, as reported by the International Diabetes Federation in January 2022. Additionally, chronic diseases, including cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes, contribute to a significant percentage (74%) of global non-communicable disease-related deaths, with 41 million deaths annually, according to the World Health Organization in September 2022. This rising prevalence of chronic and rare diseases is a key driver fueling the growth of the oligonucleotide synthesis market.

The increasing demand for personalized medicine is expected to contribute to the market's growth. Personalized medicine, also known as precision medicine, leverages an individual's genetic and molecular profile to tailor prevention and treatment strategies. Oligonucleotide synthesis plays a vital role in developing precision medicines by providing small-molecule drugs composed of synthetically modified RNA or DNA strands that target specific cellular processes. The Personalized Medicine Coalition (PMC) reported in October 2022 that there will be over 75,000 genetic testing products and 300 personalized medicines on the market, catering to individuals with various types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. The increasing demand for personalized medicine is thus identified as a significant driver for the oligonucleotide synthesis market's growth.

Product innovation stands out as a key trend gaining traction in the oligonucleotide synthesis market, with major companies actively developing innovative products to maintain their market positions. One notable example is the launch of Syntax by DNA Script, a France-based DNA synthesis company, in July 2021. Syntax is a benchtop DNA printer designed for molecular biology and genomics applications, enabling on-site synthesis of DNA oligonucleotides (oligos) in genomics workflows. Powered by the enzymatic DNA synthesis (EDS) technology, Syntax is the company's first tabletop nucleic acid printer, offering a comprehensive system with a desktop DNA printer, consumables and reagent kits, and management software. The printer, with a quick setup time of less than 15 minutes, can synthesize significant lengths of DNA in a matter of hours and provides purified, quantified, and normalized oligos for subsequent research stages.

Major companies in the oligonucleotide synthesis market are focusing on introducing novel synthesis techniques, such as de novo synthesis, to gain a competitive edge. In March 2023, Ansa Biotechnologies, a U.S.-based biotechnology company, achieved a significant milestone by successfully de novo synthesizing the longest oligonucleotide in the world, comprising 1005 bases. This sequence encodes a crucial part of an Adeno-Associated Virus (AAV) vector used in gene therapy development. Overcoming challenges related to strong secondary structures and high GC content, this achievement allows for the direct synthesis of gene-length sequences, impacting the fields of genetic engineering and biotechnology.

In October 2021, Biotage AB, a prominent life sciences company based in Sweden, successfully completed the acquisition of ATDBio, a leading oligonucleotide synthesis company based in the United Kingdom. The financial details of the transaction remain undisclosed. This strategic acquisition positions Biotage to expand its portfolio by incorporating platform solutions for DNA and RNA oligonucleotide synthesis and purification.

Major companies operating in the oligonucleotide synthesis market report are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

North America was the largest region in the oligonucleotide synthesis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oligonucleotide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oligonucleotide synthesis market consists of revenues earned by entities by providing non-coding RNA inhibition, splicing modulation, gene activation, and programmed gene editing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The oligonucleotide synthesis market also includes sales of RNAi oligonucleotides, antisense oligonucleotides, condensation activators, sulphur-transfer reagents, and deprotection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oligonucleotide Synthesis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oligonucleotide synthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oligonucleotide synthesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oligonucleotide synthesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Custom Oligos; Predesigned Oligos
  • 2) By Product Type: Oligonucleotides; Reagents; Equipment; Services; Purification; Modification
  • 3) By Application: Therapeutic Applications; Research Applications; Diagnostic Applications
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE HealthCare Technologies Inc.; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oligonucleotide Synthesis Market Characteristics

3. Oligonucleotide Synthesis Market Trends And Strategies

4. Oligonucleotide Synthesis Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Oligonucleotide Synthesis Market Size and Growth

  • 5.1. Global Oligonucleotide Synthesis Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Oligonucleotide Synthesis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Oligonucleotide Synthesis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oligonucleotide Synthesis Market Segmentation

  • 6.1. Global Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Custom Oligos
  • Predesigned Oligos
  • 6.2. Global Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oligonucleotides
  • Reagents
  • Equipment
  • Services
  • Purification
  • Modification
  • 6.3. Global Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Therapeutic Applications
  • Research Applications
  • Diagnostic Applications

7. Oligonucleotide Synthesis Market Regional And Country Analysis

  • 7.1. Global Oligonucleotide Synthesis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Oligonucleotide Synthesis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oligonucleotide Synthesis Market

  • 8.1. Asia-Pacific Oligonucleotide Synthesis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oligonucleotide Synthesis Market

  • 9.1. China Oligonucleotide Synthesis Market Overview
  • 9.2. China Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oligonucleotide Synthesis Market

  • 10.1. India Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oligonucleotide Synthesis Market

  • 11.1. Japan Oligonucleotide Synthesis Market Overview
  • 11.2. Japan Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oligonucleotide Synthesis Market

  • 12.1. Australia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oligonucleotide Synthesis Market

  • 13.1. Indonesia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oligonucleotide Synthesis Market

  • 14.1. South Korea Oligonucleotide Synthesis Market Overview
  • 14.2. South Korea Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oligonucleotide Synthesis Market

  • 15.1. Western Europe Oligonucleotide Synthesis Market Overview
  • 15.2. Western Europe Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oligonucleotide Synthesis Market

  • 16.1. UK Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oligonucleotide Synthesis Market

  • 17.1. Germany Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oligonucleotide Synthesis Market

  • 18.1. France Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oligonucleotide Synthesis Market

  • 19.1. Italy Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oligonucleotide Synthesis Market

  • 20.1. Spain Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oligonucleotide Synthesis Market

  • 21.1. Eastern Europe Oligonucleotide Synthesis Market Overview
  • 21.2. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oligonucleotide Synthesis Market

  • 22.1. Russia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oligonucleotide Synthesis Market

  • 23.1. North America Oligonucleotide Synthesis Market Overview
  • 23.2. North America Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oligonucleotide Synthesis Market

  • 24.1. USA Oligonucleotide Synthesis Market Overview
  • 24.2. USA Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oligonucleotide Synthesis Market

  • 25.1. Canada Oligonucleotide Synthesis Market Overview
  • 25.2. Canada Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oligonucleotide Synthesis Market

  • 26.1. South America Oligonucleotide Synthesis Market Overview
  • 26.2. South America Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oligonucleotide Synthesis Market

  • 27.1. Brazil Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oligonucleotide Synthesis Market

  • 28.1. Middle East Oligonucleotide Synthesis Market Overview
  • 28.2. Middle East Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oligonucleotide Synthesis Market

  • 29.1. Africa Oligonucleotide Synthesis Market Overview
  • 29.2. Africa Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oligonucleotide Synthesis Market Competitive Landscape And Company Profiles

  • 30.1. Oligonucleotide Synthesis Market Competitive Landscape
  • 30.2. Oligonucleotide Synthesis Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE HealthCare Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eurofins Scientific SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Oligonucleotide Synthesis Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Nitto Denko Avecia Inc.
  • 31.3. Alnylam Pharmaceuticals Inc.
  • 31.4. Maravai Life Sciences
  • 31.5. LGC Limited
  • 31.6. Ionis Pharmaceuticals Inc.
  • 31.7. GenScript Inc.
  • 31.8. Ajinomoto Bio-Pharma Services
  • 31.9. Sarepta Therapeutics Inc.
  • 31.10. Integrated DNA Technologies Inc.
  • 31.11. Twist Bioscience Corporation
  • 31.12. Eurogentec SA
  • 31.13. Kaneka Eurogentec S.A.
  • 31.14. Biocomma Limited
  • 31.15. Bio-Synthesis Inc.

32. Global Oligonucleotide Synthesis Market Competitive Benchmarking

33. Global Oligonucleotide Synthesis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Oligonucleotide Synthesis Market

35. Oligonucleotide Synthesis Market Future Outlook and Potential Analysis

  • 35.1 Oligonucleotide Synthesis Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Oligonucleotide Synthesis Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Oligonucleotide Synthesis Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer